Influence of immunosuppressive therapy on infectious complications in renal transplant recipients.
Klauser
R
R
Department of Medicine II, University of Vienna, Austria.
Zlabinger
G J
GJ
Traindl
O
O
Franz
M
M
Watschinger
B
B
Pohanka
E
E
Kudlacek
S
S
Kovarik
J
J
D000328:Adult; D000961:Antilymphocyte Serum / Q000009:adverse effects / Q000627:therapeutic use; D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use; D016470:Bacteremia / Q000453:epidemiology / Q000209:etiology*; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006084:Graft Rejection; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015994:Incidence; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000009:adverse effects / Q000627:therapeutic use; D011239:Prednisolone / Q000009:adverse effects / Q000627:therapeutic use; D012189:Retrospective Studies; D014777:Virus Diseases / Q000453:epidemiology / Q000209:etiology*
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D016572:Cyclosporine; D011239:Prednisolone; D001379:Azathioprine